This is the first pathway out of two pathways which deals with DNA damage response. It has two central gene products (ATM and ATR) which are connected to the sources of DNA damage (in blue). The two central genes can be divides furthermore into their most important genes. In the ATM pathway are the most important genes TP53 and CHEK2 and on the other hand in the ATR pathway is this CHEK1.
If it is not mentioned different, the processes take place in the cell cytoplasm.
The goal of this first pathway is to give an overview of the most important gene products, processes and changes in the cell condition through the DNA damage response pathway and at the same time to keep it clearly arranged
Cellular Process
efb
d5f
e6f
d5f
e6f
e6f
a35
c56
e48
d50
b66
ac5
b4f
a1b
df4
d5f
e6f
a35
d5f
efb
c48
d5f
c48
e6f
e6f
a35
bf4
bf4
c48
bf4
c48
d5f
d5f
efb
a35
d5f
d5f
d5f
e48
dab
af9
c04
da1
e6f
a35
c56
e48
d50
b66
ac5
b4f
a1b
df4
d5f
c56
e48
d50
b66
ac5
b4f
a1b
df4
c56
e48
d50
b66
ac5
b4f
a1b
df4
c56
e48
d50
b66
ac5
b4f
a1b
df4
c56
e48
d50
b66
ac5
b4f
a1b
df4
c56
e48
d50
b66
ac5
b4f
a1b
df4
e6f
a35
d5f
d5f
15719025
PubMed
The role of BH3-only proteins in the immune system.
Nat Rev Immunol
2005
Strasser A
15339658
PubMed
Wagging the dogma; tissue-specific cell cycle control in the mouse embryo.
Cell
2004
Pagano M
Jackson PK
17568790
PubMed
CDC25 phosphatases in cancer cells: key players? Good targets?
Nat Rev Cancer
2007
Boutros R
Lobjois V
Ducommun B
17128209
PubMed
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.
Nat Rev Cancer
2006
Toledo F
Wahl GM
17768402
PubMed
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.
Nat Rev Genet
2007
Wang W
15343279
PubMed
Transcription - guarding the genome by sensing DNA damage.
Nat Rev Cancer
2004
Ljungman M
Lane DP
16921403
PubMed
Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all.
Nat Rev Mol Cell Biol
2006
Gil J
Peters G
15668327
PubMed
Chromosomal instability in oral cancer cells.
J Dent Res
2005
Reshmi SC
Gollin SM
18004398
PubMed
CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?
Nat Rev Cancer
2007
Antoni L
Sodha N
Collins I
Garrett MD
19111245
PubMed
Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale?
Lancet Oncol
2009
Chargari C
Toillon RA
Macdermed D
Castadot P
Magn��٠N
15688066
PubMed
p53: traffic cop at the crossroads of DNA repair and recombination.
Nat Rev Mol Cell Biol
2005
Sengupta S
Harris CC
17943134
PubMed
The impact of a negligent G2/M checkpoint on genomic instability and cancer induction.
Nat Rev Cancer
2007
L��Ωbrich M
Jeggo PA
14634621
PubMed
The Bcl-2 family: roles in cell survival and oncogenesis.
Oncogene
2003
Cory S
Huang DC
Adams JM
14993903
PubMed
Targeting the checkpoint kinases: chemosensitization versus chemoprotection.
Nat Rev Cancer
2004
Zhou BB
Bartek J
17060944
PubMed
Polycomb silencers control cell fate, development and cancer.
Nat Rev Cancer
2006
Sparmann A
van Lohuizen M
15545627
PubMed
Living with or without cyclins and cyclin-dependent kinases.
Genes Dev
2004
Sherr CJ
Roberts JM
17380161
PubMed
p53 in health and disease.
Nat Rev Mol Cell Biol
2007
Vousden KH
Lane DP
16805667
PubMed
Surviving the breakup: the DNA damage checkpoint.
Annu Rev Genet
2006
Harrison JC
Haber JE